Concepedia

Pauline Mélénec

PM

Statistics

Publications

12

Citations

1.2K

H-Index

11

Active since

2014

Affiliations

Garvan Institute of Medical Research(Current)

St Vincent's Clinic

UNSW Sydney

Cancer Research UK Scotland Institute

The Kinghorn Cancer Centre

Pauline Mélénec is an author at Garvan Institute of Medical Research specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2014–2024

12

Publications

12

Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis

Claire Vennin, Venessa Chin, Sean Warren et al. · Science Translational Medicine · 2017 · 266 citations

, , +16

Structural mechanism of cGAS inhibition by the nucleosome

G.R. Pathare, Alexiane Decout, Selene Glück et al. · Nature · 2020 · 266 citations · Full text

, , +14

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan

Claire Vennin, Pauline Mélénec, Romain Rouet et al. · Nature Communications · 2019 · 261 citations · Full text

, , +17

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

Jessica L. Chitty, Michelle Yam, Lara Perryman et al. · Nature Cancer · 2023 · 124 citations · Full text

, , +13

Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pancreatic Cancer

James R. W. Conway, Sean Warren, David Herrmann et al. · Cell Reports · 2018 · 73 citations · Full text

, , +15

1–5 of 12